Back to calendar
Spero Therapeutics, Inc. (SPRO) Earnings
SPRO reports earnings on Monday, November 16, 2026
earnings report
November 16, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.14
Actual EPS: $-0.16
EPS surprise: 5.88%
Company overview
Market Cap$65.8M
PriceUSD 1.13
P/E10.35
EPS (TTM)0.11
52-week high3.08
52-week low1.08
SectorHealth Technology
IndustryBiotechnology
Employees25